Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCHW) Cash & Current Investments (2022 - 2025)

Historic Cash & Current Investments for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to $3.6 million.

  • Envoy Medical's Cash & Current Investments fell 1962.03% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 1962.03%. This contributed to the annual value of $5.5 million for FY2024, which is 2999.05% up from last year.
  • Per Envoy Medical's latest filing, its Cash & Current Investments stood at $3.6 million for Q3 2025, which was down 1962.03% from $5.3 million recorded in Q2 2025.
  • Envoy Medical's 5-year Cash & Current Investments high stood at $22.2 million for Q3 2023, and its period low was $68000.0 during Q2 2023.
  • Its 4-year average for Cash & Current Investments is $4.0 million, with a median of $3.6 million in 2025.
  • Over the last 5 years, Envoy Medical's Cash & Current Investments had its largest YoY gain of 726431.16% in 2023, and its largest YoY loss of 8574.27% in 2023.
  • Over the past 4 years, Envoy Medical's Cash & Current Investments (Quarter) stood at $183000.0 in 2022, then skyrocketed by 2204.92% to $4.2 million in 2023, then grew by 29.99% to $5.5 million in 2024, then plummeted by 35.14% to $3.6 million in 2025.
  • Its Cash & Current Investments was $3.6 million in Q3 2025, compared to $5.3 million in Q2 2025 and $5.3 million in Q1 2025.